To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NGDNTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
275 supporting clones for gene NGDN back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DW417702 Liver .a 1 to 300 7 to 305       299/305
(98 %)
7 diff
(97.8 %id)
DW428907 Liver .a 1 to 269 7 to 274       268/274
(97 %)
6 diff
(97.9 %id)
DT220200 brain .a 4 to 578 1 to 575   tiling clone,   575/575
(100 %)
2 diff
(99.7 %id)
BU594548 mixed (pool of 40 RNAs) .a 4 to 494 1 to 495       495/857
(57 %)
16 diff
(98.2 %id)
NM_001042635.1   .a 5 to 1146 1 to 1142 exact RefSeq,   1142/1142
(100 %)
0 diff
(100 %id)
AL035939 brain .a 7 to 553 1 to 547       547/547
(100 %)
5 diff
(99.1 %id)
BU934531 mixed (pool of 40 RNAs) .a 7 to 795 1 to 790       790/791
(99 %)
18 diff
(97.8 %id)
BG531402 embryonal carcinoma, testis .a 9 to 835 1 to 829       829/833
(99 %)
13 diff
(98.5 %id)
BG714569 brain, hypothalamus .a 9 to 757 1 to 755       753/755
(99 %)
18 diff
(97.7 %id)
AW610542 uterus .a 10 to 456 28 to 474       447/474
(94 %)
21 diff
(95.6 %id)
AW793037 uterus .a 10 to 456 28 to 474       447/474
(94 %)
21 diff
(95.6 %id)
CD692075 normal nasopharynx .a 10 to 610 26 to 626       601/626
(96 %)
12 diff
(98.1 %id)
BQ277513 mixed (pool of 40 RNAs) .a 10 to 722 1 to 716       716/972
(73 %)
12 diff
(98.8 %id)
AK291875 skeletal muscle .a 12 to 1105 1 to 1094 exact     1094/1094
(100 %)
2 diff
(99.9 %id)
BG484704 lung .a 12 to 720 1 to 714       713/719
(99 %)
22 diff
(97.0 %id)
DA895441 skeletal muscle .a 13 to 571 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
CD683696 normal nasopharynx .a 14 to 636 26 to 648       623/648
(96 %)
6 diff
(99.1 %id)
BG617927 Liver .a 14 to 745 1 to 731       731/736
(99 %)
10 diff
(98.7 %id)
CD709325 normal nasopharynx .a 15 to 493 23 to 500       478/500
(95 %)
7 diff
(98.6 %id)
CD703874 normal nasopharynx .a 16 to 555 28 to 567       540/567
(95 %)
12 diff
(97.9 %id)
CD710632 normal nasopharynx .a 16 to 149 25 to 158       134/158
(84 %)
6 diff
(96.3 %id)
BG724295 testis .a 16 to 688 1 to 673       673/673
(100 %)
2 diff
(99.8 %id)
CD523448 pooled .a 16 to 662 1 to 654       654/730
(89 %)
16 diff
(97.9 %id)
CB857891 anterior tongue, pooled .a 17 to 573 1 to 557       557/557
(100 %)
2 diff
(99.7 %id)
CB857820 anterior tongue, pooled .a 17 to 585 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
BG426454 Kidney .a 18 to 745 1 to 733       733/933
(78 %)
11 diff
(98.9 %id)
BG546821 lung .a 18 to 745 1 to 734       734/755
(97 %)
17 diff
(97.8 %id)
CD357004 Blood vessels - aorta, basilar and artery .a 18 to 722 1 to 720       720/820
(87 %)
37 diff
(95.5 %id)
BM146548 leukopheresis .a 18 to 446 1 to 428       428/468
(91 %)
14 diff
(97.1 %id)
BC030817 placenta .a 19 to 1124 1 to 1106 exact available from MGC, AAA   1106/1106
(100 %)
3 diff
(99.8 %id)
AA308353 colon .a 20 to 421 9 to 415       407/415
(98 %)
12 diff
(97.2 %id)
BF218596 brain, glioblastoma .a 21 to 666 1 to 644       644/645
(99 %)
16 diff
(97.6 %id)
BF668620 brain, primitive neuroectoderm .a 21 to 685 1 to 651       653/870
(75 %)
27 diff
(96.9 %id)
DB260449 uterus .a 21 to 594 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
CD522169 pooled .a 22 to 722 1 to 708       708/762
(92 %)
16 diff
(98.0 %id)
CB108026 Liver .a 22 to 505 1 to 484       484/484
(100 %)
4 diff
(99.2 %id)
DA728924   .a 22 to 775 2 to 755   fully sequenced, capped   754/754
(100 %)
4 diff
(99.5 %id)
DB498235 hypothalamus .a 23 to 517 1 to 496       496/496
(100 %)
4 diff
(99.2 %id)
BF246147 brain, glioblastoma .a 23 to 741 1 to 720       720/859
(83 %)
40 diff
(95.4 %id)
DA056439 cerebellum .a 25 to 550 2 to 527   capped   526/526
(100 %)
2 diff
(99.7 %id)
BF207686 bladder, carcinoma, cell line .a 25 to 745 1 to 720       722/739
(97 %)
23 diff
(96.9 %id)
BF700890 brain, primitive neuroectoderm .a 25 to 698 1 to 675       677/886
(76 %)
32 diff
(96.4 %id)
BM724177 eye, fetal eye .a 26 to 775 1 to 748   fully sequenced,   748/748
(100 %)
2 diff
(99.8 %id)
DA899565 skeletal muscle .a 27 to 589 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
BM049323 carcinoma, cell line, Prostate .a 29 to 557 12 to 541       530/541
(97 %)
7 diff
(98.8 %id)
EL735662 mixed .a 32 to 645 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
CV569679 cornea, eye .a 34 to 594 1 to 561       561/561
(100 %)
0 diff
(100 %id)
CR985821 T-Lymphocytes .a 34 to 976 1 to 944       944/945
(99 %)
4 diff
(99.6 %id)
BI198807 brain, neuroblastoma .a 35 to 739 1 to 716       716/993
(72 %)
28 diff
(97.2 %id)
BG678032 skin, squamous cell carcinoma .a 36 to 652 1 to 617       617/617
(100 %)
2 diff
(99.7 %id)
AI132997 Liver .a 39 to 596 1 to 558       558/558
(100 %)
2 diff
(99.7 %id)
CR609427 Neuroblastoma Cot 50-normalized .a 43 to 1131 1 to 1089   tiling clone,   1089/1089
(100 %)
0 diff
(100 %id)
CR610556 HeLa cells Cot 25-normalized .a 43 to 1089 1 to 1047       1047/1047
(100 %)
0 diff
(100 %id)
BX376782 Neuroblastoma Cot 50-normalized .a 43 to 1095 1 to 1045   fully sequenced, AAA   1045/1045
(100 %)
20 diff
(98.1 %id)
BX400735   .a 43 to 775 1 to 733   fully sequenced,   733/733
(100 %)
2 diff
(99.8 %id)
AA205044   .a 45 to 451 1 to 413       413/416
(99 %)
9 diff
(97.9 %id)
CR599950 Placenta Cot 25-normalized .a 58 to 1085 1 to 1028       1028/1028
(100 %)
0 diff
(100 %id)
BX379895 Placenta Cot 25-normalized .a 58 to 1014 1 to 956       956/960
(99 %)
1 diff
(99.9 %id)
BQ267704 insulinoma, Pancreas .a 64 to 606 8 to 550   fully sequenced,   543/550
(98 %)
6 diff
(99.0 %id)
BU071871 insulinoma, Pancreas .a 64 to 606 8 to 550   fully sequenced,   543/550
(98 %)
6 diff
(99.0 %id)
BU074928 Pancreas, Purified pancreatic islet .a 80 to 606 1 to 527   fully sequenced,   527/527
(100 %)
6 diff
(98.9 %id)
BX376781 Neuroblastoma Cot 50-normalized .a 145 to 1110 964 to 1   fully sequenced,   964/964
(100 %)
10 diff
(99.0 %id)
TI_154192847   .a 169 to 1086 51 to 965       915/1027
(89 %)
21 diff
(98.0 %id)
TI_154193885   .a 169 to 1120 44 to 991       946/951
(99 %)
20 diff
(97.9 %id)
CR598616 HeLa cells Cot 25-normalized .a 256 to 1131 1 to 876       876/876
(100 %)
0 diff
(100 %id)
BX400941   .a 256 to 1096 849 to 8       842/849
(99 %)
6 diff
(99.3 %id)
BX400942   .a 256 to 1131 1 to 877       877/877
(100 %)
4 diff
(99.6 %id)
TI_227715251   .a 314 to 1131 914 to 99       816/1062
(76 %)
3 diff
(99.8 %id)
BI198286 brain, neuroblastoma .a 329 to 1001 1 to 674       674/803
(83 %)
9 diff
(98.9 %id)
BE311969 brain, neuroblastoma .a 350 to 1124 1 to 772   AAA   772/772
(100 %)
10 diff
(98.8 %id)
BG031301 breast, mammary adenocarcinoma, cell line .a 433 to 1123 1 to 697       697/697
(100 %)
7 diff
(99.0 %id)
CD365732 Alveolar Macrophage, lung .a 444 to 1124 699 to 19   AAA   681/681
(100 %)
2 diff
(99.8 %id)
TI_154141770   .a 449 to 1130 80 to 761       682/713
(95 %)
28 diff
(96.1 %id)
TI_154100116   .a 453 to 1146 793 to 100       694/802
(86 %)
2 diff
(99.8 %id)
TI_149273736   .a 454 to 1145 773 to 82   AAA   692/864
(80 %)
2 diff
(99.8 %id)
TI_149285517   .a 467 to 1124 749 to 93   AAA   657/1130
(58 %)
4 diff
(99.7 %id)
BM968180 lung, Primary Lung Epithelial Cells .a 467 to 1145 695 to 17   AAA   679/679
(100 %)
2 diff
(99.8 %id)
BM984934 lung .a 476 to 1124 667 to 19   AAA   649/649
(100 %)
1 diff
(99.9 %id)
AW603075 breast .a 480 to 974 1 to 493       493/509
(96 %)
13 diff
(97.5 %id)
BM969625 lung, Primary Lung Epithelial Cells .a 529 to 1124 615 to 19   AAA   597/597
(100 %)
4 diff
(99.4 %id)
BQ272305 insulinoma, Pancreas .a 545 to 1124 597 to 18   fully sequenced, AAA   580/580
(100 %)
2 diff
(99.7 %id)
BU073389 insulinoma, Pancreas .a 545 to 1124 597 to 18   fully sequenced, AAA   580/580
(100 %)
1 diff
(99.9 %id)
BU074638 Pancreas, Purified pancreatic islet .a 546 to 1124 593 to 15   fully sequenced, AAA   579/579
(100 %)
9 diff
(98.5 %id)
AI269117 Kidney .a 570 to 1126 556 to 1       556/590
(94 %)
16 diff
(97.3 %id)
CA441177 Fibrosarcoma .a 578 to 1145 586 to 19   AAA   568/568
(100 %)
3 diff
(99.5 %id)
BQ446568 Knee, Osteoarthritic Cartilage .a 592 to 1124 551 to 19   AAA   533/541
(98 %)
1 diff
(99.9 %id)
AA909407 pooled .a 602 to 1145 557 to 14   AAA   544/544
(100 %)
10 diff
(98.2 %id)
BQ013133 placenta .a 638 to 1128 509 to 19   AAA   491/491
(100 %)
3 diff
(99.4 %id)
DB569330 hypothalamus .a 659 to 1117 1 to 459     Submitted on the opposite strand 459/466
(98 %)
2 diff
(99.6 %id)
AI309011 2 pooled tumors (clear cell type), Kidney .a 671 to 1126 459 to 4       456/459
(99 %)
1 diff
(99.8 %id)
AA806279 germinal center B cell .a 684 to 1131 454 to 7       448/454
(98 %)
0 diff
(100 %id)
AW769203 colon, moderately-differentiated adenocarcinoma .a 692 to 1117 433 to 8       426/433
(98 %)
0 diff
(100 %id)
DB544545 hippocampus .a 693 to 1124 1 to 432     Submitted on the opposite strand 432/432
(100 %)
1 diff
(99.8 %id)
BX400734   .a 714 to 1089 377 to 1   fully sequenced,   377/377
(100 %)
13 diff
(96.6 %id)
BM680339 eye, fetal eye .a 714 to 1143 448 to 19   fully sequenced, AAA   430/430
(100 %)
0 diff
(100 %id)
AA588305 breast .a 731 to 1131 403 to 3       401/403
(99 %)
0 diff
(100 %id)
AA969421 pooled .a 735 to 1131 401 to 5       397/401
(99 %)
0 diff
(100 %id)
T49712 ovary .a 742 to 1107 16 to 391   fully sequenced,   376/391
(96 %)
20 diff
(94.9 %id)
AA204988   .a 742 to 1117 386 to 8       379/393
(96 %)
4 diff
(99.0 %id)
DB353968   .a 742 to 1117 383 to 8   fully sequenced,   376/383
(98 %)
1 diff
(99.8 %id)
AI161184 brain, glioblastoma (pooled) .a 745 to 1117 381 to 8       374/381
(98 %)
0 diff
(100 %id)
AA903278 leiomyosarcoma, soft tissue .a 748 to 1124 389 to 13   AAA   377/377
(100 %)
1 diff
(99.8 %id)
AA688038 germinal center B cell .a 752 to 1131 386 to 7       380/386
(98 %)
0 diff
(100 %id)
AI267632 brain, frontal lobe (see description) .a 773 to 991 239 to 21       219/239
(91 %)
0 diff
(100 %id)
CD103478 Pooled-Skin .a 783 to 1128 1 to 346   AAA   346/346
(100 %)
4 diff
(98.9 %id)
F37284 pectoral muscle (after mastectomy) .a 800 to 1114 1 to 319       317/319
(99 %)
10 diff
(96.9 %id)
BM148527 leukopheresis .a 800 to 1125 341 to 16   AAA   326/327
(99 %)
7 diff
(97.9 %id)
BU570203 testis .a 819 to 1123 1 to 305       305/340
(89 %)
10 diff
(97.1 %id)
F31188 pectoral muscle (after mastectomy) .a 849 to 1104 1 to 256       256/256
(100 %)
1 diff
(99.7 %id)
AW582816   .a 864 to 1131 268 to 1       268/271
(98 %)
3 diff
(98.9 %id)
FN079155 breast carcinoma .a 879 to 990 111 to 1     Submitted on the opposite strand 111/115
(96 %)
1 diff
(99.2 %id)
EC512861 Prostate .a 884 to 994 1 to 112       112/112
(100 %)
3 diff
(97.4 %id)
T97758 liver and spleen .a 901 to 1117 226 to 8       219/336
(65 %)
2 diff
(99.5 %id)
C00081   .a 902 to 1117 1 to 218       218/225
(96 %)
3 diff
(98.7 %id)
T49713 ovary .a 915 to 1123 217 to 9   fully sequenced,   209/217
(96 %)
0 diff
(100 %id)
AW978259   .a 916 to 1061 146 to 1     Submitted on the opposite strand 146/194
(75 %)
0 diff
(100 %id)
NM_015514.1   .b 1 to 1588 1 to 1588 exact RefSeq,   1588/1588
(100 %)
0 diff
(100 %id)
AL050003 brain .b 13 to 2199 1 to 2187 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2187/2187
(100 %)
4 diff
(99.9 %id)
BG427978 Kidney .b 14 to 766 1 to 756       756/757
(99 %)
8 diff
(99.0 %id)
BG503536 embryonal carcinoma, testis .b 14 to 794 1 to 782       780/782
(99 %)
9 diff
(98.9 %id)
BG622035 placenta .b 14 to 789 1 to 781       781/784
(99 %)
16 diff
(98.0 %id)
BM149386 leukopheresis .b 14 to 310 1 to 297       297/311
(95 %)
22 diff
(93.0 %id)
DB453667 testis .b 15 to 287 1 to 280       280/341
(82 %)
9 diff
(97.4 %id)
BQ646088 hepatocellular carcinoma, cell line, Liver .b 16 to 851 4 to 853       850/895
(94 %)
33 diff
(96.4 %id)
FN136351 breast carcinoma .b 18 to 91 1 to 74       74/74
(100 %)
4 diff
(94.6 %id)
FN171711 breast carcinoma .b 20 to 100 1 to 81       81/81
(100 %)
5 diff
(93.9 %id)
BU602901 mixed (pool of 40 RNAs) .b 21 to 836 1 to 815       815/815
(100 %)
9 diff
(98.9 %id)
BE799582 lung, small cell carcinoma .b 24 to 759 11 to 746       736/747
(98 %)
7 diff
(99.1 %id)
BQ645488 hepatocellular carcinoma, cell line, Liver .b 26 to 880 1 to 858       858/969
(88 %)
33 diff
(96.6 %id)
TI_1948221480   .b 28 to 478 128 to 578   fully sequenced,   451/578
(78 %)
2 diff
(99.7 %id)
TI_1948221828   .b 28 to 953 128 to 1047   fully sequenced,   920/1047
(87 %)
17 diff
(98.4 %id)
TI_1948222009   .b 28 to 117 126 to 215   fully sequenced,   90/117
(76 %)
0 diff
(100 %id)
CN360147 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 30 to 450 1 to 421       421/421
(100 %)
0 diff
(100 %id)
BI759250 pooled colon, kidney, stomach .b 30 to 877 1 to 856       856/858
(99 %)
18 diff
(98.0 %id)
BQ420576 large cell carcinoma, lung .b 30 to 862 1 to 834       834/941
(88 %)
17 diff
(98.2 %id)
CT000707 T-Lymphocytes .b 30 to 896 1 to 866       866/869
(99 %)
4 diff
(99.6 %id)
BQ439933 melanotic melanoma, skin .b 32 to 889 1 to 861       861/861
(100 %)
4 diff
(99.6 %id)
BQ938509 epidermoid carcinoma, cell line, lung .b 34 to 741 1 to 713       713/988
(72 %)
13 diff
(98.7 %id)
CN360150 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 39 to 625 11 to 597       587/597
(98 %)
9 diff
(98.5 %id)
BM046313 carcinoma, cell line, Prostate .b 39 to 950 1 to 915       915/915
(100 %)
8 diff
(99.2 %id)
TI_57146075   .b 39 to 877 70 to 916       847/918
(92 %)
24 diff
(97.4 %id)
TI_1948221656   .b 39 to 956 137 to 1056   fully sequenced,   920/1056
(87 %)
23 diff
(97.9 %id)
CN360149 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 40 to 600 1 to 561       561/561
(100 %)
0 diff
(100 %id)
BM926432 brain .b 41 to 957 15 to 933       919/1064
(86 %)
18 diff
(98.4 %id)
BQ945149 carcinoma, cell line, Prostate .b 41 to 898 1 to 865       865/905
(95 %)
9 diff
(99.1 %id)
BX279614 brain .b 46 to 563 1 to 518       518/518
(100 %)
2 diff
(99.7 %id)
BE265257 lung, small cell carcinoma .b 50 to 541 1 to 492       492/492
(100 %)
1 diff
(99.8 %id)
BE265543 lung, small cell carcinoma .b 50 to 695 1 to 648       648/648
(100 %)
3 diff
(99.6 %id)
BE891294 melanotic melanoma, skin .b 50 to 741 1 to 696       696/876
(79 %)
12 diff
(98.7 %id)
BI259613 cervical carcinoma cell line, cervix .b 52 to 898 1 to 848       850/880
(96 %)
17 diff
(98.1 %id)
BQ892463 sympathetic trunk .b 53 to 957 1 to 906       906/908
(99 %)
16 diff
(98.3 %id)
FN158826 breast carcinoma .b 57 to 152 95 to 1     Submitted on the opposite strand 95/95
(100 %)
1 diff
(99.0 %id)
CN360151 embryonic stem cells, cell lines H1, H7, andH9 .b 64 to 774 1 to 711       711/711
(100 %)
2 diff
(99.8 %id)
TI_1948222010   .b 69 to 957 1032 to 144   tiling clone, fully sequenced,   889/1032
(86 %)
11 diff
(99.0 %id)
H94380 placenta .b 136 to 572 1 to 448       448/471
(95 %)
21 diff
(95.6 %id)
CN360148 embryonic stem cells, cell lines H1, H7, andH9 .b 149 to 426 1 to 278       278/278
(100 %)
2 diff
(99.3 %id)
CF128065 Chondrosarcoma Lung Metastasis cell lines, lung .b 165 to 915 1 to 751       751/751
(100 %)
6 diff
(99.3 %id)
CF127438 Chondrosarcoma Lung Metastasis cell lines, lung .b 165 to 898 1 to 734       734/737
(99 %)
9 diff
(98.8 %id)
BG217205   .b 169 to 848 21 to 701       681/816
(83 %)
39 diff
(95.3 %id)
BG191187   .b 172 to 957 1 to 784       784/807
(97 %)
13 diff
(98.4 %id)
EB388097 eye, optic nerve .b 175 to 923 1 to 749       749/749
(100 %)
2 diff
(99.8 %id)
BI117431 lung, small cell carcinoma .b 187 to 898 49 to 760       712/805
(88 %)
20 diff
(97.6 %id)
BE887221 leiomyosarcoma, uterus .b 192 to 764 208 to 780       573/780
(73 %)
13 diff
(98.4 %id)
Z20416   .b 193 to 411 225 to 8       218/228
(95 %)
4 diff
(98.3 %id)
FN160914 breast carcinoma .b 195 to 283 1 to 88       88/88
(100 %)
1 diff
(98.9 %id)
T32554 gallbladder .b 198 to 490 1 to 293       293/293
(100 %)
0 diff
(100 %id)
AW965137   .b 199 to 854 1 to 656       656/657
(99 %)
2 diff
(99.7 %id)
BG029679 breast, mammary adenocarcinoma, cell line .b 208 to 955 1 to 746       746/960
(77 %)
12 diff
(98.8 %id)
AW369178 head_neck .b 216 to 858 39 to 677       639/677
(94 %)
11 diff
(98.4 %id)
AW369227 head_neck .b 220 to 868 658 to 10       649/662
(98 %)
7 diff
(99.0 %id)
AW369079 head_neck .b 228 to 868 670 to 31       640/716
(89 %)
10 diff
(98.7 %id)
AW369070 head_neck .b 231 to 868 647 to 13       635/661
(96 %)
8 diff
(98.8 %id)
AA091050   .b 238 to 601 1 to 358       359/359
(100 %)
12 diff
(96.7 %id)
AW369148 head_neck .b 238 to 868 647 to 17       631/647
(97 %)
5 diff
(99.3 %id)
FN159138 breast carcinoma .b 239 to 342 104 to 1     Submitted on the opposite strand 104/111
(93 %)
10 diff
(91.0 %id)
BM748605 Ascites, stomach .b 303 to 409 1 to 108       108/108
(100 %)
6 diff
(94.5 %id)
BM746800 Ascites, stomach .b 304 to 843 1 to 541       541/541
(100 %)
8 diff
(98.6 %id)
BM746843 Ascites, stomach .b 304 to 715 1 to 412       412/412
(100 %)
0 diff
(100 %id)
BM756903 Ascites, stomach .b 304 to 829 1 to 526       526/526
(100 %)
2 diff
(99.7 %id)
BM756669 Ascites, stomach .b 304 to 825 1 to 522       522/522
(100 %)
0 diff
(100 %id)
BM766533 Ascites, stomach .b 304 to 789 1 to 486       486/486
(100 %)
6 diff
(98.8 %id)
BM766471 Ascites, stomach .b 304 to 877 1 to 574       574/574
(100 %)
0 diff
(100 %id)
BM770764 Ascites, stomach .b 304 to 791 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BM748903 Ascites, stomach .b 304 to 898 1 to 594       594/595
(99 %)
8 diff
(98.7 %id)
BM749711 Ascites, stomach .b 304 to 810 1 to 506       506/506
(100 %)
9 diff
(98.3 %id)
BM749719 Ascites, stomach .b 304 to 527 1 to 225       225/225
(100 %)
8 diff
(96.5 %id)
BM757609 Ascites, stomach .b 304 to 934 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BM757636 Ascites, stomach .b 304 to 934 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BM758913 Ascites, stomach .b 304 to 474 1 to 171       171/171
(100 %)
8 diff
(95.4 %id)
BM758914 Ascites, stomach .b 304 to 898 1 to 595       595/598
(99 %)
2 diff
(99.7 %id)
BM758359 Ascites, stomach .b 304 to 594 1 to 291       291/291
(100 %)
0 diff
(100 %id)
BM758176 Ascites, stomach .b 304 to 925 1 to 622       622/622
(100 %)
0 diff
(100 %id)
BM743311 Ascites, stomach .b 306 to 843 1 to 538       538/538
(100 %)
6 diff
(98.9 %id)
BM750578 Ascites, stomach .b 306 to 802 1 to 498       498/498
(100 %)
7 diff
(98.6 %id)
BM750579 Ascites, stomach .b 306 to 932 1 to 629       629/629
(100 %)
9 diff
(98.6 %id)
CB146359 Liver .b 308 to 895 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BM750633 Ascites, stomach .b 309 to 829 6 to 525       520/525
(99 %)
6 diff
(98.9 %id)
BE167479 head_neck .b 313 to 652 2 to 345       344/353
(97 %)
9 diff
(97.5 %id)
FN161003 breast carcinoma .b 316 to 417 1 to 106       106/110
(96 %)
5 diff
(95.5 %id)
FN119094 breast carcinoma .b 320 to 408 1 to 86       86/87
(98 %)
4 diff
(95.5 %id)
BM845742 myeloma .b 343 to 697 1 to 355       355/355
(100 %)
0 diff
(100 %id)
W21827 eye, retina .b 346 to 878 15 to 557       543/742
(73 %)
15 diff
(98.0 %id)
C14579   .b 354 to 687 1 to 334       334/334
(100 %)
0 diff
(100 %id)
C15311   .b 354 to 677 1 to 322       322/322
(100 %)
4 diff
(98.8 %id)
TI_1948221481   .b 417 to 957 680 to 140   fully sequenced,   541/680
(79 %)
0 diff
(100 %id)
FN107058 breast carcinoma .b 432 to 504 73 to 1     Submitted on the opposite strand 73/73
(100 %)
1 diff
(98.7 %id)
AW404763 lymph .b 446 to 883 9 to 446       438/446
(98 %)
6 diff
(98.7 %id)
FN119496 breast carcinoma .b 464 to 542 80 to 1     Submitted on the opposite strand 80/84
(95 %)
3 diff
(96.5 %id)
CB134141 Liver .b 498 to 717 220 to 1     Submitted on the opposite strand 220/232
(94 %)
5 diff
(97.9 %id)
FN094210 breast carcinoma .b 566 to 631 1 to 66       66/67
(98 %)
3 diff
(95.6 %id)
FN090205 breast carcinoma .b 661 to 734 1 to 73       73/80
(91 %)
6 diff
(92.5 %id)
BF087273 head_neck .b 676 to 851 188 to 14       175/188
(93 %)
0 diff
(100 %id)
FN065872 breast carcinoma .b 679 to 769 91 to 1     Submitted on the opposite strand 91/91
(100 %)
0 diff
(100 %id)
FN140357 breast carcinoma .b 681 to 772 94 to 3     Submitted on the opposite strand 92/94
(97 %)
0 diff
(100 %id)
FN114914 breast carcinoma .b 702 to 799 98 to 1     Submitted on the opposite strand 98/98
(100 %)
0 diff
(100 %id)
TI_1948221829   .b 867 to 957 234 to 144   fully sequenced,   91/135
(67 %)
0 diff
(100 %id)
TI_1948221657   .b 884 to 957 216 to 143   fully sequenced,   74/118
(62 %)
0 diff
(100 %id)
DB568257 hypothalamus .b 1090 to 1570 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
DB568114 hypothalamus .b 1094 to 1570 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
DB565140 hypothalamus .b 1113 to 1570 1 to 458     Submitted on the opposite strand 458/458
(100 %)
0 diff
(100 %id)
AW513866 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1116 to 1567 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
DB553406 hypothalamus .b 1126 to 1570 1 to 445     Submitted on the opposite strand 445/445
(100 %)
0 diff
(100 %id)
AW969323   .b 1209 to 1559 356 to 6     Submitted on the opposite strand 351/498
(70 %)
0 diff
(100 %id)
AW291005   .b 1209 to 1565 372 to 16   AAA   357/371
(96 %)
3 diff
(99.2 %id)
BF509658   .b 1209 to 1565 372 to 16   AAA   357/364
(98 %)
3 diff
(99.2 %id)
AA469101 colon .b 1244 to 1559 316 to 1       316/316
(100 %)
1 diff
(99.7 %id)
AV742364 cord Blood .b 1293 to 1566 1 to 264   AAA   264/264
(100 %)
10 diff
(96.3 %id)
BX370383   .b 1404 to 1573 1 to 171       171/173
(98 %)
6 diff
(96.6 %id)
FN129216 breast carcinoma .b 1432 to 1539 1 to 110       110/110
(100 %)
2 diff
(98.2 %id)
BG219475   .c 1 to 579 14 to 592   tiling clone,   579/592
(97 %)
6 diff
(99.0 %id)
CR984895 T-Lymphocytes .c 512 to 1349 1 to 838 exact tiling clone,   838/838
(100 %)
2 diff
(99.8 %id)
BI457868 brain, hypothalamus .d 1 to 714 5 to 718       718/718
(100 %)
5 diff
(99.4 %id)
DB497087 hypothalamus .d 1 to 480 1 to 480   tiling clone,   480/480
(100 %)
0 diff
(100 %id)
DB484453 hypothalamus .d 2 to 442 1 to 441       441/441
(100 %)
1 diff
(99.8 %id)
DB494106 hypothalamus .d 2 to 535 1 to 535       535/535
(100 %)
2 diff
(99.7 %id)
DB496943 hypothalamus .d 2 to 491 1 to 490       490/490
(100 %)
2 diff
(99.6 %id)
DB497204 hypothalamus .d 2 to 480 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
DB139928 thymus .d 10 to 544 2 to 537   capped   536/536
(100 %)
3 diff
(99.5 %id)
DB161701 thymus .d 10 to 592 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
DA171322 amygdala .d 11 to 554 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
CD559034 White Matter .d 11 to 496 1 to 493       493/808
(61 %)
17 diff
(97.9 %id)
DB031290 testis .d 11 to 557 2 to 549   capped   548/548
(100 %)
3 diff
(99.5 %id)
DB108944 thymus .d 11 to 587 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
DA953362 Spleen .d 12 to 562 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB114641 thymus .d 12 to 555 2 to 545   capped   544/547
(99 %)
4 diff
(99.3 %id)
DA921211 small intestine .d 15 to 572 2 to 559   capped   558/558
(100 %)
3 diff
(99.5 %id)
DA953276 Spleen .d 15 to 574 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB119575 thymus .d 15 to 557 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
DA191072 amygdala .d 17 to 592 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
BM802900 duodenal adenocarcinoma, cell line, small intestine .d 176 to 1139 1 to 970   tiling clone,   970/1013
(95 %)
12 diff
(98.9 %id)
BQ653219 hepatocellular carcinoma, cell line, Liver .d 994 to 1716 25 to 747   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 723/747
(96 %)
7 diff
(99.1 %id)
BM928476 hepatocellular carcinoma, cell line, Liver .d 995 to 1711 1 to 718   AAA   718/724
(99 %)
6 diff
(99.2 %id)
FN136784 breast carcinoma .d 1062 to 1157 95 to 1     Submitted on the opposite strand 95/95
(100 %)
2 diff
(97.9 %id)
CR598946 Placenta Cot 25-normalized .e 1 to 629 1 to 629 exact tiling clone,   629/629
(100 %)
0 diff
(100 %id)
AL552961 placenta, Placenta Cot 25-normalized .e 1 to 629 1 to 629 F14X     629/629
(100 %)
7 diff
(98.9 %id)
AL553062 placenta, Placenta Cot 25-normalized .e 1 to 556 557 to 1 E7X E51X Y56X S110*     557/557
(100 %)
3 diff
(99.5 %id)
BX371173 Placenta Cot 25-normalized .e 1 to 588 589 to 1 E7X E26D K33Q K40Q R41T ...     589/589
(100 %)
11 diff
(98.2 %id)
BX371174 Placenta Cot 25-normalized .e 1 to 624 1 to 624 exact     624/629
(99 %)
2 diff
(99.7 %id)
BG704840 brain, hippocampus .f 1 to 731 1 to 732   tiling clone,   732/733
(99 %)
11 diff
(98.5 %id)
DB475731 hippocampus .f 6 to 505 1 to 500       500/500
(100 %)
1 diff
(99.8 %id)
BF208617 bladder, carcinoma, cell line .f 6 to 804 1 to 571       551/986
(55 %)
36 diff
(96.4 %id)
DT219447 brain .g 1 to 674 1 to 674   tiling clone,   674/674
(100 %)
3 diff
(99.6 %id)
BG165362 hypernephroma, cell line, Kidney .g 7 to 786 1 to 774 L62* tiling clone,   776/775
(100 %)
34 diff
(95.7 %id)
AW878300 ovary .h 1 to 414 5 to 418 Q2L S3I Q4R E5R D6T ... tiling clone,   414/422
(98 %)
12 diff
(97.2 %id)
AA253121 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 56 to 513 1 to 458   tiling clone,   458/458
(100 %)
2 diff
(99.6 %id)
AA253250 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 57 to 494 1 to 437       437/437
(100 %)
1 diff
(99.8 %id)
TI_154109216   .h 138 to 984 912 to 72   tiling clone,   841/1044
(80 %)
0 diff
(100 %id)
AA369966 Prostate .h 186 to 452 1 to 267       267/267
(100 %)
0 diff
(100 %id)
AW957117   .h 186 to 606 1 to 421       421/423
(99 %)
24 diff
(94.4 %id)
AA252977 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 617 to 982 375 to 10       366/375
(97 %)
0 diff
(100 %id)
AA252953 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 619 to 969 383 to 33       351/383
(91 %)
0 diff
(100 %id)
AV711000 adrenal cortico adenoma for Cushing'ssyndrome .i 1 to 737 9 to 716 exact tiling clone,   716/778
(92 %)
49 diff
(93.8 %id)
BG476592 melanotic melanoma, skin .i 178 to 1013 1 to 840   tiling clone,   840/850
(98 %)
18 diff
(97.9 %id)
BG745531 Spleen .i 191 to 468 1 to 279   fully sequenced,   279/279
(100 %)
2 diff
(99.3 %id)
BG745787 Spleen .i 438 to 944 510 to 1   tiling clone, fully sequenced,   510/510
(100 %)
5 diff
(99.1 %id)
AK022215 mammary gland .j 1 to 2763 1 to 2759 exact tiling clone, available from FLJ,   2759/2759
(100 %)
9 diff
(99.7 %id)
AU121571 mammary gland .j 2 to 849 2 to 845 exact capped   844/845
(99 %)
12 diff
(98.6 %id)
BI915961 brain .j 5 to 908 1 to 920 exact tiling clone,   920/1130
(81 %)
27 diff
(97.7 %id)
TI_57238941   .j 5 to 908 31 to 950 exact     920/1160
(79 %)
33 diff
(97.2 %id)
BI018259 marrow .j 448 to 831 383 to 1       383/383
(100 %)
6 diff
(98.5 %id)
FN169843 breast carcinoma .j 513 to 595 1 to 82       82/82
(100 %)
4 diff
(95.2 %id)
AU147361 mammary gland .j 2205 to 2763 551 to 1   tiling clone,   551/551
(100 %)
13 diff
(97.7 %id)
BU664841 blood .k 1 to 614 1 to 614 exact tiling clone,   614/614
(100 %)
0 diff
(100 %id)
AI630305 blood .l 1 to 454 454 to 1 M28V V74A tiling clone,   454/454
(100 %)
2 diff
(99.6 %id)
BI670492 brain, hypothalamus .l 291 to 587 10 to 307   tiling clone, AAA   298/307
(97 %)
2 diff
(99.4 %id)
TI_44345447   .l 291 to 587 154 to 451   AAA   298/451
(66 %)
8 diff
(98.3 %id)
DW426046 Liver .m 1 to 272 13 to 283   tiling clone,   275/283
(97 %)
11 diff
(96.2 %id)
AK124318 trachea Gene NGDN, variant not shown       available from FLJ, This clone was ignored    
AV652416 corresponding non cancerous liver tissue Gene NGDN, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BG105307 adrenal cortex carcinoma, cell line, adrenal gland Gene NGDN, variant not shown         This clone was ignored    
TI_149279682   Gene NGDN, variant not shown         This clone was ignored    
DB212720 trachea Gene NGDN, variant not shown       capped This clone was ignored    
DB348842 trachea Gene NGDN, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C